These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13784204)

  • 1. [Results of the immunization in various age groups with live poliomyelitis vaccines in 1960].
    WELKE G; STARKE G
    Dtsch Gesundheitsw; 1961 Jun; 16():1165-7. PubMed ID: 13784204
    [No Abstract]   [Full Text] [Related]  

  • 2. Present position of immunization against poliomyelitis with live virus vaccines.
    SABIN AB
    Br Med J; 1959 Mar; 1(5123):663-80. PubMed ID: 13629086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunization with live polio vaccine].
    VODOPIJA I
    Lijec Vjesn; 1962 Jun; 84():545-51. PubMed ID: 13926382
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization of man against poliomyelitis with attenuated preparations of living virus.
    KOPROWSKI H
    Ann N Y Acad Sci; 1955 Sep; 61(4):1039-49. PubMed ID: 13340613
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of infants with formalinized poliomyelitis vaccine (Salk type).
    SPIGLAND I; GOLDBLUM N
    Pediatrics; 1960 May; 25():812-21. PubMed ID: 13833339
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization against poliomyelitis with a trivalent oral vaccine.
    COX HR; CABASSO VJ; EMBIL J; MARKHAM FS; MOSES MJ; MOYER AW; ROCA-GARCIA M; RUEGSEGGER JM
    Pathol Microbiol (Basel); 1961; 24(Suppl)():61-72. PubMed ID: 13696125
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.
    PERKINS FT; YETTS R; GAISFORD W
    Br Med J; 1959 Mar; 1(5123):680-2. PubMed ID: 13629087
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 10. Earlier poliomyelitis immunization with quadruple antigen. Diphtheria and tetanus toxoids and pertussis and poliomyelitis vaccines.
    SAUER LW
    Q Bull Northwest Univ Med Sch; 1959; 33(3):259-61. PubMed ID: 14441933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the immunizing effect of small doses of poliomyelitis vaccine inoculated by intradermal route in adult subjects].
    ROSA A; LA PLACA M
    Riv Ital Ig; 1959; 19():143-8. PubMed ID: 14438768
    [No Abstract]   [Full Text] [Related]  

  • 13. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunization of newborn infants with antipoliomyelitis trivalent oral vaccine].
    CAMPILLO SAINZ C; ORNELAS HERNANDEZ A; DE MUCHA MACIAS J; NAVA SE
    Bol Oficina Sanit Panam; 1962 Aug; 53():130-5. PubMed ID: 13876085
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines.
    DANE DS; DICK GW
    Br Med J; 1957 Jan; 1(5010):70-4. PubMed ID: 13383195
    [No Abstract]   [Full Text] [Related]  

  • 16. [The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine].
    KELLER W; SAUTHOFF R
    Dtsch Med Wochenschr; 1955 Sep; 80(37):1329-31. PubMed ID: 13261706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of mass oral immunization with live vaccine prepared from Sabin's strain on epidemiological processes in poliomyelitis].
    CUMAKOV MP
    Cesk Epidemiol Mikrobiol Imunol; 1960 Jul; 9():406-7. PubMed ID: 13813269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antipoliomyelitic vaccination in the infant. Study of simple immunization and immunization by vaccine combinations].
    GRUMBACH R; ROGER F; AYMARD B
    Sem Hop Ther Paris; 1960 Jul; 36():591-9. PubMed ID: 13829843
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunization with non-virulent live poliomyelitis viruses].
    SCHAER M; BUSER F
    Schweiz Med Wochenschr; 1960 Jun; 90():618-23. PubMed ID: 14442368
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine.
    CONNOLLY JH; DANE DS; DICK GW; FISHER OD; MCKEOWN F
    Br Med J; 1957 Jan; 1(5010):59-65. PubMed ID: 13383193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.